These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 5306550)

  • 1. Activity of antimony dextran glycoside (RL-712) against visceral leishmaniasis in the hamster.
    Mikhail JW; Khayyal MT; Girgis NI
    Bull World Health Organ; 1969; 40(2):327-8. PubMed ID: 5306550
    [No Abstract]   [Full Text] [Related]  

  • 2. Leishmania donovani: therapeutic and prophylaciic action of antimony dextran glycoside (RL-712) in the golden hamster.
    Mikhail JW; Mansour NS
    Exp Parasitol; 1975 Jun; 37(3):348-52. PubMed ID: 1126418
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetic and toxicological studies of antimony dextran glycoside (RL-712).
    Casals JB
    Br J Pharmacol; 1972 Oct; 46(2):281-8. PubMed ID: 4651773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral pentoxifylline and pentavalent antimony for treatment of leishmaniasis: promising but inconclusive evidence of superiority, compared with antimony monotherapy.
    Ojha RP; Cervantes D; Fischbach LA
    Clin Infect Dis; 2007 Oct; 45(8):1104; author reply 1005-6. PubMed ID: 17879933
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined liposomal immuno- and chemotherapy of visceral leishmaniasis.
    Everlien H; Hockertz S
    Arzneimittelforschung; 1999 Nov; 49(11):954-61. PubMed ID: 10604050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current concepts in parasitology. Leishmaniasis.
    Marsden PD
    N Engl J Med; 1979 Feb; 300(7):350-2. PubMed ID: 759896
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chemotherapeutic effectiveness of stibomen in experimental leishmaniasis and trypanosomiasis].
    Pershin GN; Moskalenko NIu
    Med Parazitol (Mosk); 1967; 36(4):422-7. PubMed ID: 5612807
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pluri-focal cutaneous leishmaniasis treated with intralesional glucantime].
    Duperrat B; Puissant A; Fischer R; Badillet G; Mascaro JM
    Bull Soc Fr Dermatol Syphiligr; 1966; 73(2):219-20. PubMed ID: 5914173
    [No Abstract]   [Full Text] [Related]  

  • 9. Relative insensitivity of a Kenyan strain of Leishmania donovani to pentavalent antimony therapy in hamsters.
    Hanson WL; Waits VB; Hendricks LD; Hockmeyer WT; Davidson DE; Chapman WL
    J Parasitol; 1983 Apr; 69(2):446-7. PubMed ID: 6854484
    [No Abstract]   [Full Text] [Related]  

  • 10. [N-methylglucamine antimoniate (glucantime) in therapy of infantile visceral leishmaniasis; a further case of autocthonous infantile visceral leishmaniasis on the island of Elba].
    CAMBI P
    Minerva Dermatol; 1955 Apr; 30(4):126-8. PubMed ID: 14383431
    [No Abstract]   [Full Text] [Related]  

  • 11. Interleukin 10 receptor blockade--pentavalent antimony treatment in experimental visceral leishmaniasis.
    Murray HW
    Acta Trop; 2005 Mar; 93(3):295-301. PubMed ID: 15716043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late cutaneous leishmaniasis.
    Hart M; Livingood CS; Goltz RW; Totonchy M
    Arch Dermatol; 1969 Apr; 99(4):455-8. PubMed ID: 5769330
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antimony resistance in the treatment of visceral leishmaniasis].
    MIRZOIAN NA
    Med Parazitol (Mosk); 1957; 26(3):277-80. PubMed ID: 13482777
    [No Abstract]   [Full Text] [Related]  

  • 14. Leishmania tropica infections.
    Long JC
    Arch Dermatol; 1977 Jan; 113(1):108. PubMed ID: 831613
    [No Abstract]   [Full Text] [Related]  

  • 15. Leishmaniasis in the Sudan Republic. 27. Lack of effect of chloroquine and pyrimethamine on visceral leishmaniasis in the hamster.
    Mansour NS; McConnell E
    Am J Trop Med Hyg; 1966 Mar; 15(2):146-8. PubMed ID: 5910521
    [No Abstract]   [Full Text] [Related]  

  • 16. American cutaneous leishmaniasis: disappearance of amastigotes from lesions during antimonial therapy.
    Mayrink W; Raso P; Melo MN; Michalick MS; Magalhães PA; Williams P; da Costa CA; Dias M
    Rev Inst Med Trop Sao Paulo; 1983; 25(6):265-9. PubMed ID: 6672988
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative evaluation of effectiveness of antimony preparations in the treatment of visceral leishmaniasis].
    MIRZOIAN NA
    Med Parazitol (Mosk); 1954; 23(2):161-4. PubMed ID: 13175906
    [No Abstract]   [Full Text] [Related]  

  • 18. [Kala-azar in the Netherlands].
    van der Linde DL; Meuwissen OJ; van Gorp LH
    Ned Tijdschr Geneeskd; 1969 Aug; 113(33):1413-8. PubMed ID: 5801539
    [No Abstract]   [Full Text] [Related]  

  • 19. [Secretion of antimony and stilbamidine in the treatment of visceral leishmaniasis in children].
    MIKHAILOV VG
    Farmakol Toksikol; 1959; 22(2):175-8. PubMed ID: 13653152
    [No Abstract]   [Full Text] [Related]  

  • 20. [Leishmaniasis vegetans and terramycin].
    Pinillos VC; Lovatón AC
    Dermatol Int; 1967; 6(3):165-7. PubMed ID: 5590120
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.